CD47 and neoplasm: Because D2.1 tumor persistence through the dormant phase was unaffected by adaptive immunity, variation in cell surface expression of major histocompatibility complex class I (MHC-I), programmed death-ligand 1 (PD-L1), and CD47 were investigated as potential mechanisms for dormancy-mediated immune evasion (17, 18).